Optimization of Drug Prescriptions in the Care Pathway for the Elderly, With the Final Objective of Reducing the Iatrogenic Risk
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Sep 7, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The IATROPREV project is a clinical trial aimed at improving how medications are prescribed for elderly patients, particularly those who are taking multiple drugs. The goal is to reduce the risks that can come from taking too many medications or from interactions between them. This trial, taking place in the Hauts-de-France region, involves collaboration between hospitals, healthcare professionals, and local health authorities to better coordinate care and share important information about patients' medications.
To participate in this trial, individuals need to be hospitalized in a geriatric medicine department and may have experienced problems related to their medications during their hospital stay. This includes situations where multiple changes to their drugs were made, or where new medications could interact with existing ones. Participants can expect to be part of a process that looks closely at their prescriptions and care, with the aim of ensuring their treatments are safer and more effective. It's important to note that only patients currently hospitalized in the geriatric department can join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient hospitalized in the geriatric medicine department
- • Potential involvement of a drug in hospitalization or potential or proven iatrogenic event during hospitalization;
- • Numerous therapeutic modifications (3 or more);
- • Drug interaction or introction of a new drug with one or more drug interactions;
- • Medicinal product with a narrow therapeutic marge drug requiring close monitoring.
- Exclusion Criteria:
- • patient non hospitalized in the geriatric medicine department
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials